Correlation Between Vanguard High and Incyte
Can any of the company-specific risk be diversified away by investing in both Vanguard High and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanguard High and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanguard High Dividend and Incyte, you can compare the effects of market volatilities on Vanguard High and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanguard High with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanguard High and Incyte.
Diversification Opportunities for Vanguard High and Incyte
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Vanguard and Incyte is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Vanguard High Dividend and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Vanguard High is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanguard High Dividend are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Vanguard High i.e., Vanguard High and Incyte go up and down completely randomly.
Pair Corralation between Vanguard High and Incyte
Considering the 90-day investment horizon Vanguard High Dividend is expected to generate 0.58 times more return on investment than Incyte. However, Vanguard High Dividend is 1.71 times less risky than Incyte. It trades about 0.03 of its potential returns per unit of risk. Incyte is currently generating about -0.04 per unit of risk. If you would invest 10,127 in Vanguard High Dividend on January 20, 2024 and sell it today you would earn a total of 1,467 from holding Vanguard High Dividend or generate 14.49% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 99.8% |
Values | Daily Returns |
Vanguard High Dividend vs. Incyte
Performance |
Timeline |
Vanguard High Dividend |
Incyte |
Vanguard High and Incyte Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vanguard High and Incyte
The main advantage of trading using opposite Vanguard High and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanguard High position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.Vanguard High vs. Vanguard Dividend Appreciation | Vanguard High vs. Schwab Dividend Equity | Vanguard High vs. Vanguard Real Estate | Vanguard High vs. Vanguard Total Stock |
Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |